Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
Shore N, Higano CS, George DJ, Sternberg CN, Saad F, Tombal B, Miller K, Kalinovsky J, Jiao X, Tangirala K, Sartor O. Shore N, et al. Among authors: kalinovsky j. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):680-688. doi: 10.1038/s41391-020-0236-0. Epub 2020 May 13. Prostate Cancer Prostatic Dis. 2020. PMID: 32404868 Free PMC article.
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States.
George DJ, Sartor O, Miller K, Saad F, Tombal B, Kalinovský J, Jiao X, Tangirala K, Sternberg CN, Higano CS. George DJ, et al. Among authors: kalinovsky j. Clin Genitourin Cancer. 2020 Aug;18(4):284-294. doi: 10.1016/j.clgc.2019.12.019. Epub 2020 Jan 7. Clin Genitourin Cancer. 2020. PMID: 32057714 Free article.
Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice.
Dizdarevic S, Petersen PM, Essler M, Versari A, Bourre JC, la Fougère C, Valdagni R, Paganelli G, Ezziddin S, Kalinovský J, Bayh I, Du Y. Dizdarevic S, et al. Among authors: kalinovsky j. Eur J Nucl Med Mol Imaging. 2019 May;46(5):1102-1110. doi: 10.1007/s00259-019-4261-y. Epub 2019 Jan 12. Eur J Nucl Med Mol Imaging. 2019. PMID: 30637501 Free PMC article. Clinical Trial.